AKT is a serine/threonine kinase acting as a signal transduction protein and downstream mediator of phosphatidylinositol-3-kinase (PI3K) that plays a central role in tumour progression and influences prognosis in several cancers (Lim et al, 2005; Tang et al, 2006). This evidence concerns the gene MARK2 and cancer.